IM Cannabis Corp. (IMCC) stock

IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026Score 4/30

$0.55−0.02 (-3.83%)

Close on Nov 12, 2026Market cap $3.26MP/E –Yield –

IM Cannabis EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

IM Cannabis has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IMCC.

Revenue growth1.3% · median 33.2%

Gross margin17.7% · median 35.5%

Operating margin-21.2% · median -25.4%

Net margin-20.7% · median -29.5%

Advertisement
300 × 250

See a number that looks wrong?